SAN.PA : Summary for SANOFI - Yahoo Finance

U.S. Markets closed

Sanofi (SAN.PA)


Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
76.81-1.26 (-1.61%)
At close: 5:39PM CET
People also watch
FP.PABN.PACS.PAOR.PAAI.PA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close78.07
Open77.51
Bid71.12 x 1000
Ask71.74 x 44000
Day's Range76.71 - 78.16
52 Week Range62.50 - 79.07
Volume1,901,516
Avg. Volume2,917,127
Market Cap96.44B
Beta0.74
PE Ratio (TTM)23.57
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.35 (4.05%)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire7 hours ago

    Sanofi : Disclosure of trading in own shares

    Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible ...

  • Forbes11 hours ago

    5 Trump-Proof Pharma Dividends Up To 5.3%

    Donald Trump needed just 20 minutes to knock $24.6 billion in value from the nine biggest Big Pharma companies. That was the statistic bandied about recently when the president-elect, at a much-anticipated press conference, declared that pharmaceuticals are “getting away with murder.” That’s ironic, because investors targeting the sure-fire dividends of

  • Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink
    Investor's Business Daily3 days ago

    Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink

    Amgen will likely triumph in a patent battle with Regeneron and Sanofi, Leerink says.